Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3)

Genomics

Volumn 40, Issue 3, 1997, Pages 425-434

  Kotani, Masato ^a,b   Tanaka, Issei ^a   Ogawa, Yoshihiro ^a   Usui, Takeshi ^a   Tamura, Naohisa ^a   Mori, Kiyoshi ^a   Narumiya, Shuh ^a   Yoshimi, Teruya ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA LIBRARY; DNA SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN CELL; INTRON; MEMBRANE POTENTIAL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYADENYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TATA BOX; TISSUE SPECIFICITY;

EID: 0031569412     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.4585     Document Type: Article

References (34)

1. 3 prostanoid receptor. FEBS Lett. 338: 170-174.
2. Blackwell, T. K., and Weintraub, H. (1990). Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250: 1104-1110.
3. Breathnach, R., and Chambon, P. (1981). Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50: 349-383.
4. Breibart, R. E., Andreadis, A., and Nadal-Ginard, B. (1987). Alternative splicing: A ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu. Rev. Biochem. 56: 467-495.
5. 2 receptor. J. Biol. Chem. 269: 6163-6169.
6. Briggs, M. R., Kadonaga, J. T., Bell, S. P., and Tjian, R. (1986). Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234: 47-52.
7. Coleman, R. A., Kennedy, I., Humphrey, P. P. A., Bunce, K., and Lumley, P. (1990). "Comprehensive Medical Chemistry," Vol. 3, pp. 643-714, Pergamon Press, Oxford.
8. Coleman, R. A., Smith, W. L., and Narumiya, S. (1994). International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229.
9. 2 dopamine receptor isoform. Nature 342: 923-926.
10. 2 dopamine receptor. Proc. Natl. Acad. Sci. USA 86: 9762-9766.
11. 2 receptor. Nature 349: 617-620.
12. Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., and Narumiya, S. (1994). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. USA 91: 11192-11196.
13. Howe, K. M., Reakes, C. F. L., and Watson, R. J. (1990). Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J. 9: 161-169.
14. Isse, N., Ogawa, Y., Tamura, N., Masuzaki, H., Mori, K., Okazaki, T., Satoh, N., Shigemoto, M., Yoshimasa, Y., Nishi, S., Hosoda, K., Inazawa, J., and Nakao, K. (1995). Structural organization and chromosomal assignment of the human obese gene. J. Biol. Chem. 270: 27728-27733.
15. 3 subtype generated by alternative messenger RNA splicing: Multiple second messenger systems and tissue-specific distributions. Mol. Pharmacol. 48: 869-879.
16. Lenardo, M. J., and Baltimore, D. (1989). NF-kB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229.
17. Maniatis, T., Fritsch, E. F., and Sambrock, J. (1989). "Molecular Cloning: A Laboratory Manual," 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
18. Mitchell, P. J., Wang, C., and Tjian, R. (1987). Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50: 847-861.
19. 2, and leukotrienes. In "The Pharmacological Basis of Therapeutics" (A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad, Eds.), pp. 660-673, Macmillan, New York.
20. 2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929.
21. Namba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, A., Ito, S., Ichikawa, A., and Narumiya, S. (1993). Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365: 166-170.
22. 2 receptor gene. J. Biol. Chem. 268: 25253-25259.
23. Ogawa, Y., Tanaka, I., Inoue, M., Yoshitake, Y., Isse, N., Nakagawa, O., Usui, T., Ito, H., Yoshimasa, T., Narumiya, S., and Nakao, K. (1995). Structural organization and chromosomal assignment of the human prostacyclin receptor gene. Genomics 27: 142-148.
24. Patthy, L. (1987). Intron-dependent evolution: Preferred types of exons and introns. FEBS Lett. 214: 1-7.
25. Pearse, R. N., Feinman, R., and Ravetch, J. V. (1991). Characterization of the promotor of the human gene encoding the high-affinity IgG receptor: Transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. USA 88: 11305-11309.
26. 2 receptor. J. Biol. Chem. 269: 19256-19261.
27. 3 receptors: Evidence of three variants with differing carboxyl termini. Br. J. Pharmacol. 112: 377-385.
28. 2. Eur. J. Biochem. 228: 23-30.
29. Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P. H., and Journot, L. (1993). Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175.
30. Toh, H., Ichikawa, A., and Narumiya, S. (1995). Molecular evolution of receptors for eicosanoids. FEBS Lett. 361: 17-21.
31. 2 receptor: Two molecular forms generated by alternative splicing. EMBO J. 8: 4025-4034.
32. Wagner, B. J., Hayes, T. E., Hoban, C. J., and Cochran, B. H. (1990). The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9: 4477-4484.
33. Wickens, M., and Stephenson, P. (1984). Role of the conserved AAU-AAA sequence: Four AAUAAA point mutants prevent messenger RNA 3′ end formation. Science 226: 1045-1051.
34. Wilson, T., and Treisman, R. (1988). Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature 336: 396-399.